Study Comparing R-mabHD and a Combination of ABVD in Hodgkin's Disease

NCT00797472 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Hodgkin's Disease

Interventions

DRUG: R-mabHD
DRUG: ABVD

Sponsor

American Scitech International

Collaborators

[object Object]
[object Object]